Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
, incomplete and potentially conflicting evidence to determine confidence in environmental perception is a nontrivial challenge. We are interested to leverage evidence theory/reasoning, otherwise known as the
-
in the production of Chapter 2 of this report supporting Prof. Peter Thorne who has been selected as a Coordinating Lead Author. Closing Date: 23:30hrs (local Irish time) on Sunday, 6th July 2025
-
climate change and cities. The Chapter Scientist will assist in the production of Chapter 2 of this report supporting Prof. Peter Thorne who has been selected as a Coordinating Lead Author. Closing Date: 23
-
have been displaced due to war. Trinity College Dublin is Ireland’s premier University. We are an EU Sustainable Gender Equality Champion and we hold an Athena Swan Silver award, recognising our ongoing
-
increasing capacity and support for nurses to lead and engage in research and evidence-based practice. This position will appeal to anyone who wishes to develop their research career and profile. The salary is
-
Researcher will work with TCD researchers, lead on midwifery research projects in Portlaoise maternity hospital and host research workshops for midwives in the hospital. These workshops will be in person
-
Silver award, recognising our ongoing work to advance gender equality both within Trinity and in the Higher Education sector. Trinity is committed to supporting work-life balance and to creating a family
-
. The researcher will lead the ongoing development of a techno-economic Web-GIS tool for offshore renewable energy, secure competitive research funding, engage in the wider research activities of the ORE Group and
-
have been displaced due to war. Trinity College Dublin is Ireland’s premier University. We are an EU Sustainable Gender Equality Champion and we hold an Athena Swan Silver award, recognising our ongoing
-
process of bringing these drugs to market. To address this issue a team within the School of Pharmacy, UCC, led by the Professor of Pharmaceutics, Brendan Griffin is aiming to develop Artificial